Paul J Hastings insider trades

Open-market stock purchases and sales by Paul J Hastings, Chief Executive Officer at Nkarta, Inc, from SEC Form 4 filings since Jun 2, 2011.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -22%.

Recent trades

DateStockTradeValue
Jun 18, 2026NKTX Nkarta, IncSold$4.8K
Jun 16, 2026ENGN enGene Therapeutics IncBought (not open market)—
Jan 15, 2026NKTX Nkarta, IncSold$53.9K
Jan 6, 2026NKTX Nkarta, IncBought (not open market)—
Jan 6, 2026NKTX Nkarta, IncBought (not open market)—

Companies traded

  • NKTX Nkarta, Inc: 18 sales, last Jun 18, 2026
  • ENGN enGene Therapeutics Inc: other filings, last Jun 16, 2026
  • PCRX Pacira BioSciences, Inc: 1 buy, 21 sales, last Jun 13, 2024
  • PRTO Proteon Therapeutics Inc: other filings, last Jun 8, 2018
  • OMED OncoMed Pharmaceuticals Inc: 13 sales, last Oct 10, 2017
  • RLYP Relypsa Inc: 2 sales, last Sep 1, 2016

Get free alerts when Paul J Hastings files a new trade →